Friday, October 11, 2019

AbbVie Announces US FDA Approval of Venclexta (venetoclax) as a Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients

›
In continuation of my update on  Venclexta (venetoclax) AbbVie a research-based global biopharmaceutical  company,  announced th...
Thursday, October 10, 2019

FDA Approves Victoza (liraglutide) for the Treatment of Pediatric Patients 10 Years or Older with Type 2 Diabetes

›
In continuation of my update on Victoza (liraglutide) The U.S. Food and Drug Administration   approved Victoza (liraglutide) injection...
Wednesday, October 9, 2019

FDA Approves Symdeko (tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of CF in Children Ages 6-11 Years with Certain Mutations in the CFTR Gene

›
In continuation of my update on tezacafto     Tezacaftor                                                                           ...
Tuesday, October 8, 2019

FDA Approves Gattex (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)

›
In continuation of my update on  Teduglutide Takeda Pharmaceuticals, U.S.A., Inc. (“Takeda”), announced  that the U.S. Food and Dr...
Monday, October 7, 2019

FDA Approves Fragmin (dalteparin sodium) as First Anticoagulant for Venous Thromboembolism in Pediatric Patients

›
     In continuation of my update on  Dalteparin U.S. Food and Drug Administration,  approved   Fragmin   (dalteparin sodium) ...
Saturday, October 5, 2019

FDA Approves Revlimid (lenalidomide) In Combination with Rituximab for the Treatment of Adult Patients with Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma

›
In continuation of my update on   lenalidomide Celgene Corporation,  announced the U.S. Food and Drug Administration (FDA) approve...
Friday, October 4, 2019

FDA Approves Sorilux for Adolescent Plaque Psoriasis

›
In continuation of my update on Sorilux(calcipotriene)     Mayne Pharma Group Limited, announced that the US Food and Drug Admin...
Thursday, October 3, 2019

FDA Approves Piqray (alpelisib) as First PI3K Inhibitor for Breast Cancer

›
U.S. Food and Drug Administration approved   Piqray   (alpelisib) tablets, to be used in combination with the FDA-approved endocrine...
Wednesday, October 2, 2019

FDA Approves Jakafi (ruxolitinib) for the Treatment of Patients with Acute Graft-Versus-Host Disease

›
In continuation of my update  on  ruxolitinib Incyte Corporation   announced that the U.S. Food and Drug Administration (FDA...
Tuesday, October 1, 2019

Ocular Therapeutix Announces FDA Approval of Dextenza (dexamethasone intracanalicular insert) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery

›
In continuation of my update on  Dextenza   Ocular Therapeutix™, Inc. ), a biopharmaceutical company focused on the formulation, develop...
Saturday, September 28, 2019

AMAG Pharmaceuticals Announces FDA Approval of Vyleesi (bremelanotide injection) for Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women

›
In continuation of my update on   bremelanotide MAG Pharmaceuticals, Inc.    announced  that the U.S. Food and Drug Administrati...
Friday, September 27, 2019

FDA Approves Expanded Use of Vraylar (cariprazine) in the Treatment of Bipolar Depression

›
In continuation of my update on Cariprazine Allergan plc (NYSE: AGN) and Gedeon Richter Plc.   announced that the U.S. Food and Drug A...